Ingredient fundamentals
Urolithin A is a defined small molecule used in emerging cosmetic formulation research. Identity, assay basis, production route, particle or crystal profile and delivery behavior should be confirmed before a topical concept is screened. It is not the same as an ellagitannin extract or a finished delivery system: the quoted grade may be a neat powder, dispersion or carrier-based material. Procurement should connect identity and purity to measured solubility, particle behavior and the intended topical base.
Origin & commercial source
Urolithin A has a defined molecular identity, but commercial grades may differ in production route, impurity profile, particle form and delivery system. Natural research context and commercial supply information should be reviewed separately.
01 / MATERIAL IDENTITY
Urolithin A has a defined molecular identity, but commercial raw materials may use different production routes or supplied forms. Identity, assay basis, related substances and carrier content should be tied to the actual grade.
Limited water solubility means that particle, crystal, dispersion or delivery information is important before a conventional water-serum concept is selected.
02 / FORMULATION CHECK
Start with measured solubility, particle or crystal data and a clear active basis. Choose a water, lipid or dispersion route only after confirming the grade’s actual behavior.
Include wetting, sedimentation, crystal growth, light/heat exposure and packaging in the first screen; do not infer topical suitability from research form alone.
Technical identity
Reference values are not a batch release document. Request the current specification and COA for the offered material.
| Ingredient identity | Urolithin A; 3,8-dihydroxy-6H-benzo[c]chromen-6-one. |
|---|---|
| INCI / market status | Confirm the applicable INCI or local name, cosmetic ingredient listing, use history and safety-assessment route separately for each destination market. |
| CAS reference | 1143-70-0. |
| Molecular formula | C13H8O4. |
| Molecular weight | 228.20 g/mol. |
| Target assay | 98% target. Confirm the method, dry-basis or as-is reporting, carrier content, isomers, related substances and lot-specific result. |
| Production route | Commercial material may use synthesis or bioconversion. Confirm the actual route, origin and process statement for the offered grade. |
| Appearance | To be confirmed against the current specification. |
| Particle & crystal profile | Request particle size, crystal-form information and any carrier, encapsulation, lipid or microdispersion composition. |
| Solubility & dispersion | Water solubility is limited. Request measured solubility and solvent compatibility, then compare powder dispersion, encapsulation or lipid-delivery options in the intended base. |
| Stability | Request grade-specific data for crystallization, pH, light, heat, oxygen and packaging compatibility. |
| Storage & shelf life | To be confirmed against the current specification and supporting stability records. |
| Use boundary | Topical cosmetic R&D. Cosmetic status, claims, labeling and destination-market suitability require separate review. |
Preliminary technical values are provided for project discussion. Confirm every value against the current specification and lot-specific COA for the offered material.
Formulation concepts
These are starting concepts, not finished formulas. Set the active level, phase, process, preservation and packaging from the current specification, safety assessment and stability work.
01 / SERUM
Request measured solubility and particle data, then monitor wetting, sedimentation, crystal growth and light stability in the intended package.
02 / EMULSION
Confirm carrier composition, active basis, addition stage, particle stability and compatibility with the final packaging before moving beyond bench screening.
03 / GEL
Use a verified dispersion system and track centrifuge, heat-cycle, light and long-term physical stability before discussing cosmetic communication.
Quality & documentation
Document availability, scope and lot applicability must be confirmed for each quotation.
Specification, CAS, analytical method, reference-standard information, carrier statement and lot-specific COA.
Synthesis or bioconversion route, origin, isomers, related substances, residual solvents, heavy metals and microbial limits.
Measured solubility, particle size, crystal form, dispersion or delivery information plus pH, light and heat stability data.
SDS, safety support, INCI or local-name review, use history and destination-market regulatory assessment.
For supplier qualification, request certificates showing the holder, scope and validity dates. Certification or regulatory status must be confirmed for the offered material and supply entity.
Research context
Database records and publications provide technical context. They are not tests of the offered batch or proof of finished-cosmetic performance.
Use the PubChem record as a starting point for identity, synonyms and molecular data; confirm it against the supplied grade.
Open research sourceSeparate topical evidence from oral, sports-nutrition, animal and mechanistic studies when assessing relevance to a cosmetic project.
Open research sourceSource & evidence route
Public databases and literature provide context only. They do not replace Cosveta’s specification, TDS, SDS or lot-specific COA.
Review Urolithin A identity and cosmetic naming as a starting point; confirm the actual grade and destination-market status with Cosveta.
Open sourceSeparate skin, animal, oral and sports-nutrition research before any cosmetic communication.
Open sourceCommercial research-supplier links have been removed. Verify every current product value against Cosveta’s supplied specification and lot-specific COA.
Buyer questions
Not yet. Confirm the available grade, assay method, reporting basis and lot-specific result before purchase.
The production route is still to be confirmed for the offered material.
There is not enough grade-specific information to assume direct addition. Request solubility and dispersion data, then test the intended base.
Published research does not automatically substantiate a finished-product claim. Review the supplied material, formula, wording and destination-market requirements separately.
Sample & supply review
Request a sample, compare a batch or qualify a supply option. Include your country, formulation, required documents and order volume.
MOQ, packaging, sample availability, lead time and document scope are confirmed in the quotation.
Selected ingredientUrolithin A